Comments
The board of Dr Lal PathLabs’ wholly-owned subsidiary Pathlabs Unifiers Private Limited, on Tuesday approved signing a binding term sheet for acquisition of 70 per cent equity stake in a new company to be incorporated.
According to the term sheet, the new company will house the business of Amins Pathology Referral Laboratory, a proprietorship concern of Dr Ripal Padmani, and engaged in the pathology business in Vadodara, Gujarat, before Pathlabs Unifiers Private Limited buys 70 per cent stake in it. Shares of Dr Lal PathLabs edged down 1.52 per cent at ₹1,367.20 on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.